Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024;20(2):50-60.
doi: 10.2174/011573403X273613240125072754.

Pharmacological Triggers of Takotsubo Cardiomyopathy: An Updated Review of Evidence and Recommendations

S Arunkumar  1 , K Jegaverrapandi  2
Affiliations
Review

Pharmacological Triggers of Takotsubo Cardiomyopathy: An Updated Review of Evidence and Recommendations

S Arunkumar et al. Curr Cardiol Rev. 2024.

Abstract

Background: Previous publications in 2011, 2016, and 2022 have presented lists of drugs associated with takotsubo cardiomyopathy (TCM). This review aims to provide updated drug lists that have been reported as potential causes of TCM.

Methods: Following the same methodology employed in previous reviews, a detailed investigation was carried out in the PubMed/Medline database from June 2022 to July 2023 to identify drug-induced TCM (DITC) case reports. Various search terms related to the drug-induced transient left ventricular ballooning syndrome, ampulla cardiomyopathy, apical ballooning syndrome, drug-induced broken heart syndrome, drug triggered takotsubo cardiomyopathy, takotsubo cardiomyopathy, and iatrogenic takotsubo cardiomyopathy were utilized. Filters for fulltext availability, case reports, human studies, and English language were applied. Articles reporting drugs associated with TCM development were included in the analysis.

Results: Foremost 192 case reports were initially identified, with 75 drugs meeting the inclusion criteria after a thorough review. The latest revision identified seven drugs that might lead to TCM, with four drugs (57.14%) already reported in previous reviews and three drugs (42.86%) newly identified. Consequently, the updated drug list potentially triggering TCM in 2023 comprises a sum of 75 drugs.

Conclusion: The recent 75 drugs provided additional evidence linking to TCM development. The updated list predominantly includes drugs that induce sympathetic overstimulation, although some drugs on the list have unclear associations with sympathetic nervous system activation.

Keywords: Drug triggers; catecholamine surge; drug-induced TCM (DITC); iatrogenic; pharmacovigilance.; takotsubo myocardiopathy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest, financial or otherwise.

Figures

Fig. (1)
Fig. (1)
Preferred Reporting Items for Systemic Review and Meta-Analysis (PRISMA) [9] schematic representation for the systematic review of drugs that may induce TCM.
See this image and copyright information in PMC

References

    1. Assad J., Femia G., Pender P., Badie T., Rajaratnam R. Takotsubo syndrome: A review of presentation, diagnosis and management. Clin. Med. Insights Cardiol. 2022:16. doi: 10.1177/11795468211065782. - DOI - PMC - PubMed
    1. Fan X., Yang G., Kowitz J., Akin I., Zhou X., El-Battrawy I. Takotsubo syndrome: Translational implications and pathomechanisms. Int. J. Mol. Sci. 2022;23(4):1951. doi: 10.3390/ijms23041951. - DOI - PMC - PubMed
    1. Kido K., Guglin M. Drug-induced takotsubo cardiomyopathy. J. Cardiovasc. Pharmacol. Ther. 2017;22(6):552–563. doi: 10.1177/1074248417708618. - DOI - PubMed
    1. Shah R.M., Shah M., Shah S., Li A., Jauhar S. Takotsubo syndrome and COVID-19: Associations and implications. Curr. Probl. Cardiol. 2021;46(3):100763. doi: 10.1016/j.cpcardiol.2020.100763. - DOI - PMC - PubMed
    1. Matta A.G., Carrié D. Epidemiology, pathophysiology, diagnosis, and principles of management of takotsubo cardiomyopathy: A review. Med. Sci. Monit. 2023;29:e939020. doi: 10.12659/MSM.939020. - DOI - PMC - PubMed

MeSH terms